About

Former journalist intern. Melanie has studied in Germany and Denmark and did an internship at Novo Nordisk, where she had a glimpse to the workings of pharma. She is now a Ph.D. student at the IMP in Vienna.

Articles by Melanie De Almeida

Unexpected Side Effects: Are we Ready for the Rise of Immunotherapies?

Novartis Gains Access to Celyad’s allogenic CAR-T cell patents

Startup Scout 28 Apr 2017

This Dutch Biotech Could Boost Gene Editing of Primary Cells

BRIEF: Dutch Biotech Goes for MAA in the EU with new Immunotherapy

Novartis Negotiates its Way into the US Migraine Market

ADVERTISEMENT

New Research could Save Patients from Graft-Versus-Host Disease

The World’s Most Expensive Drugs have European Owners

Startup Scout 21 Apr 2017

No more Needles – This UK Biotech is Developing Innovative Oral Vaccines

Norway Brings Another Cancer Vaccine to the Clinic

Researchers Unmask How a New Diet can help Cure Cancer

Galapagos Shoots Past its IPO in a New Public Round of €315M

ADVERTISEMENT